Assessment of COVID -19 associated coagulopathy and multiple hemostatic markers: a single center study in Egypt.

Patients with COVID-19 infection are vulnerable to different forms of coagulopathy. This could be associated with poor outcomes. D-Dimer is a chief tool in diagnosis, severity evaluation but not thrombosis prediction. Early screening for this complication and its proper management would improve the outcome.